JP2020533321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533321A5 JP2020533321A5 JP2020513886A JP2020513886A JP2020533321A5 JP 2020533321 A5 JP2020533321 A5 JP 2020533321A5 JP 2020513886 A JP2020513886 A JP 2020513886A JP 2020513886 A JP2020513886 A JP 2020513886A JP 2020533321 A5 JP2020533321 A5 JP 2020533321A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- anesthesia
- weight
- chloroprocaine
- local analgesia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762559220P | 2017-09-15 | 2017-09-15 | |
| US62/559,220 | 2017-09-15 | ||
| PCT/IB2018/057073 WO2019053657A1 (en) | 2017-09-15 | 2018-09-14 | TOPICAL FORMULATIONS OF CHLOROPROCAINE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533321A JP2020533321A (ja) | 2020-11-19 |
| JP2020533321A5 true JP2020533321A5 (cg-RX-API-DMAC7.html) | 2021-11-04 |
Family
ID=63713967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020513886A Pending JP2020533321A (ja) | 2017-09-15 | 2018-09-14 | クロロプロカインの表面麻酔製剤 |
Country Status (22)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202139993A (zh) * | 2020-03-16 | 2021-11-01 | 瑞士商辛鐵堤卡公司 | 具有經改良之功能性的眼用氯普魯卡因(chloroprocaine)凝膠 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR930000050B1 (ko) * | 1990-08-29 | 1993-01-06 | 브리스톨-마이어즈 스퀴브 컴페니 | 항균제 겔 배합물 |
| US6218428B1 (en) * | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
| JP2004123634A (ja) * | 2002-10-03 | 2004-04-22 | Lion Corp | 眼科用組成物 |
| EP1572218A4 (en) * | 2002-12-20 | 2007-05-16 | Univ Leland Stanford Junior | LOCAL ANESTHETICS WITH ESTER COMBINATION |
| US20050137177A1 (en) * | 2003-12-18 | 2005-06-23 | Shafer Steven L. | Ester combination local anesthetic |
| AU2005309586A1 (en) * | 2004-11-24 | 2006-06-01 | Algorx Pharmaceuticals, Inc. | Capsaicinoid gel formulation and uses thereof |
| ITMI20051633A1 (it) | 2005-09-06 | 2007-03-07 | Sint Sa | Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione |
| ITMI20122120A1 (it) * | 2012-12-12 | 2014-06-13 | Sint Sa | Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta |
| CN103405576B (zh) * | 2013-08-23 | 2016-03-30 | 何学忠 | 一种治疗由焊接强光辐射引起的眼部疾病的滴眼液 |
-
2018
- 2018-09-14 MX MX2020002898A patent/MX2020002898A/es unknown
- 2018-09-14 CA CA3070336A patent/CA3070336C/en active Active
- 2018-09-14 KR KR1020207004474A patent/KR102759903B1/ko active Active
- 2018-09-14 CU CU2020000019A patent/CU20200019A7/es unknown
- 2018-09-14 EA EA202090735A patent/EA202090735A1/ru unknown
- 2018-09-14 IL IL273213A patent/IL273213B2/en unknown
- 2018-09-14 AU AU2018332212A patent/AU2018332212B2/en active Active
- 2018-09-14 US US16/131,174 patent/US10792271B2/en active Active
- 2018-09-14 CN CN201880057219.1A patent/CN111163756B/zh active Active
- 2018-09-14 EP EP18779804.6A patent/EP3681473A1/en active Pending
- 2018-09-14 JP JP2020513886A patent/JP2020533321A/ja active Pending
- 2018-09-14 WO PCT/IB2018/057073 patent/WO2019053657A1/en not_active Ceased
- 2018-09-14 PE PE2020000669A patent/PE20201281A1/es unknown
- 2018-09-14 CR CR20200133A patent/CR20200133A/es unknown
- 2018-09-14 MA MA050241A patent/MA50241A/fr unknown
- 2018-09-14 SG SG11202000992RA patent/SG11202000992RA/en unknown
-
2020
- 2020-01-17 PH PH12020550029A patent/PH12020550029A1/en unknown
- 2020-01-22 JO JOP/2020/0010A patent/JOP20200010A1/ar unknown
- 2020-01-29 ZA ZA2020/00601A patent/ZA202000601B/en unknown
- 2020-03-13 CL CL2020000665A patent/CL2020000665A1/es unknown
- 2020-03-13 CO CONC2020/0002985A patent/CO2020002985A2/es unknown
- 2020-04-15 EC ECSENADI202022313A patent/ECSP20022313A/es unknown
- 2020-09-01 US US17/008,913 patent/US11969403B2/en active Active
-
2024
- 2024-01-08 US US18/406,539 patent/US20240216323A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7224390B2 (ja) | アトロピン含有水性組成物 | |
| TWI606841B (zh) | 經穩定化的眼用半乳甘露聚糖調配物 | |
| ES2171590T7 (es) | Preparación farmacéutica para el tratamiento de rinitis agudas que contiene un simpaticomimético y pantotenol y/o ácido pantoténico | |
| TW202122094A (zh) | 含有迪夸弗索(diquafosol)或其鹽、及聚乙烯吡咯烷酮之水性眼科用組合物 | |
| JP6672512B2 (ja) | 一酸化窒素放出プロスタミドを含有する眼科用組成物 | |
| JP2020533321A5 (cg-RX-API-DMAC7.html) | ||
| JP6931257B2 (ja) | レバミピドを含有する新規ドライアイ治療用点眼組成物及びその可溶化及び安定化方法 | |
| TWI327913B (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid | |
| JP7770030B2 (ja) | 機能性の改善を有する眼科用クロロプロカインゲル | |
| JP2006083190A (ja) | 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用 | |
| KR101923519B1 (ko) | 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법 | |
| US20240216323A1 (en) | Topical formulations of chloroprocaine and methods of using same | |
| CN102210683B (zh) | 四氢嘧啶及衍生物在制备预防和治疗青光眼药物中的应用 | |
| ES2974884T3 (es) | Composición de colirio para reducir la presión intraocular | |
| JP6786504B2 (ja) | ウマにおける発熱の処置及び防止のための組成物及び方法 | |
| TW200902092A (en) | Aliphatic acid-containing N-halogenated amino acid formulations | |
| JP2016500079A (ja) | フィナフロキサシン懸濁組成物 | |
| BR112020003095B1 (pt) | Formulações tópicas de cloroprocaína e métodos de utilização dos mesmos | |
| OA19516A (en) | Topical formulations of Chloroprocaine. | |
| EA044204B1 (ru) | Офтальмологический состав хлорпрокаина для местного применения | |
| CN108348457A (zh) | 无菌水性眼用溶液的治疗用途 | |
| WO2022098324A1 (en) | A new pharmaceutical composition produced by lyophylisation method containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide active ingredient or its sodium salt | |
| JP2011105764A (ja) | 外用剤組成物 | |
| WO2016045793A1 (en) | Preservative free ophthalmic pharmaceutical composition containing propranolol for use in treatment of retinopathy of prematurity and method of preparation thereof | |
| OTHMAN et al. | Effects of Initial Intravitreal Bevacizumab (Avastin) Prior to Laser Photocoagulation in Threshold ROP |